Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of XELOX in Locally Advanced or Metastatic Gastric Cancer

NCT00354224 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT00354224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00354224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of XELOX in Locally Advanced or Metastatic Gastric Cancer
Lead sponsor
Medical University of South Carolina
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2005
Completion date
August 31, 2008
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer